Tapentadol
- Generic Name
- Tapentadol
- Brand Names
- Nucynta
- Drug Type
- Small Molecule
- Chemical Formula
- C14H23NO
- CAS Number
- 175591-23-8
- Unique Ingredient Identifier
- H8A007M585
Overview
Tapentadol is a centrally-acting synthetic analgesic with a dual mechanism of action. It is a mu-opioid receptor agonist that also inhibits norepinephrine reuptake. Tapentadol was first approved by the FDA on November 20, 2008. The extended-release formulation of tapentadol was also approved by the FDA on August 26, 2011. Used in the management of pain, tapentadol is typically reserved for patients who have limited alternative treatment options.
Background
Tapentadol is a centrally-acting synthetic analgesic with a dual mechanism of action. It is a mu-opioid receptor agonist that also inhibits norepinephrine reuptake. Tapentadol was first approved by the FDA on November 20, 2008. The extended-release formulation of tapentadol was also approved by the FDA on August 26, 2011. Used in the management of pain, tapentadol is typically reserved for patients who have limited alternative treatment options.
Indication
用于治疗严重到需要阿片类镇痛剂且替代治疗不充分的急性疼痛。
Associated Conditions
- Diabetic Peripheral Neuropathic Pain (DPN)
- Severe Acute Pain
- Severe Pain
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.